Medical Properties Trust Inc. (NYSE:MPW) price on Friday, March 17, fall -3.50% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $7.73.
A look at the stock’s price movement, the close in the last trading session was $8.01, moving within a range at $7.68 and $8.095. The beta value (5-Year monthly) was 0.97 while the PE ratio in trailing twelve months stood at 5.14. Turning to its 52-week performance, $21.63 and $7.60 were the 52-week high and 52-week low respectively. Overall, MPW moved -41.08% over the past month.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
Medical Properties Trust Inc.’s market cap currently stands at around $5.04 billion, with investors looking forward to this quarter’s earnings report slated for Apr 26, 2023 – May 01, 2023. The company has a Forward Dividend ratio of 1.16, with its dividend yield at 15.01%. As such, investors might be keen on an upside in the stock’s price ahead of the scheduled earnings report. Analysts project the company’s earnings per share (EPS) to be $0.28, which has seen fiscal year 2022 EPS growth forecast to increase to $2.01 and about $1.25 for fiscal year 2023. Per the data, EPS growth is expected to be 81.10% for 2023 and -37.80% for the next financial year.
Analysts have a consensus estimate of $372.99 million for the company’s revenue for the quarter, with a low and high estimate of $345.45 million and $386 million respectively. The average forecast suggests down to a -8.90% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue for 2022 to grow to $1.54 billion, representing a -0.50% decline on that reported in the last financial year.
Revisions could be used as tool to get short term price movement insight, and for the company that in the past seven days was no upward and no downward review(s). Turning to the stock’s technical picture we see that short term indicators suggest on average that MPW is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
14 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 7 analyst(s) rate the stock as a Hold, 6 recommend MPW as a Buy and 1 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Overweight which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
The technical evaluation for the stock shows the PEG ratio is 0.72, with MPW’s current price about -25.08% and -34.33% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 18.23, while 7-day volatility ratio is 5.61% and 4.94% in the 30-day chart. Further, Medical Properties Trust Inc. (MPW) has a beta value of 1.03, and an average true range (ATR) of 0.52. Analysts have given the company’s stock an average 52-week price target of $13.54, forecast between a low of $9.00 and high of $18.00. Looking at the price targets, the low is -16.43% off current price level while to achieve the yearly target high, price needs to move -132.86%. Nonetheless, investors will most likely welcome a -81.11% jump to $14.00 which is the analysts’ median price.
In the market, a comparison of Medical Properties Trust Inc. (MPW) and its peers suggest the former has performed considerably weaker. Data shows MPW’s intraday price has changed -3.50% in last session and -61.23% over the past year. Comparatively, Welltower Inc. (WELL) has moved -2.96% on the day and only -24.21% in the past 12 months. Looking at another peer, we see that Ventas Inc. (VTR) price has dipped -3.89% on the day. However, the stock is -24.43% off its price a year ago. Moreover, Healthpeak Properties Inc. (PEAK) is also down -3.04% in trading on the day while keeping a a downtrend of -37.42% over the past year. If we look at the PE ratio, we find that Medical Properties Trust Inc.’s ratio stands at 5.14 compared to Welltower Inc.’s 249.09. Elsewhere, the overall performance for the S&P 500 and Dow Jones Industrial shows that the indexes are down -1.10% and -1.19% respectively in the last trading.
If we refocus on Medical Properties Trust Inc. (NYSE:MPW), historical trading data shows that trading volumes averaged 23.4 million over the past 10 days and 16.68 million over the past 3 months. The company’s latest data on shares outstanding shows there are 598.05 million shares.
The 1.20% of Medical Properties Trust Inc.’s shares are in the hands of company insiders while institutional holders own 84.10% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 102.7 million on Jan 30, 2023, giving us a short ratio of 8.3. The data shows that as of Jan 30, 2023 short interest in Medical Properties Trust Inc. (MPW) stood at 17.17% of shares outstanding, with shares short falling to 104.06 million registered in Dec 29, 2022. Current price change has pushed the stock -30.61% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the MPW stock continues to rise going into the next quarter.